
BioStar Ventures appeared to be the VC, which was created in 2003. The company was established in North America in United States. The main department of described VC is located in the Petoskey.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the BioStar Ventures, startups are often financed by Safeguard Scientifics, Pontifax, Menlo Ventures. The meaningful sponsors for the fund in investment in the same round are Triventures, Safeguard Scientifics, MedFocus Fund. In the next rounds fund is usually obtained by Safeguard Scientifics, HealthQuest Capital, HBM Healthcare Investments AG.
The current fund was established by Louis Cannon. We also calculated 5 valuable employees in our database.
Opposing the other organizations, this BioStar Ventures works on 7 percentage points less the average amount of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 2-6 deals every year. When the investment is from BioStar Ventures the average startup value is 10-50 millions dollars. Speaking about the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2014. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2014.
Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Robotics, Medical Device. Among the various public portfolio startups of the fund, we may underline Corindus, SynergEyes, Domain Surgical The fund has exact preference in a number of founders of portfolio startups.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
MMI | $75M | 20 Jul 2022 | Italy, Tuscany, Italy | ||
Ablative Solutions | $91M | 13 Jun 2022 | San Jose, California, United States | ||
Foldax | $20M | 22 Jun 2020 | Salt Lake City, Utah, United States | ||
Aria CV | $31M | 25 Feb 2020 | Saint Paul, Minnesota, United States | ||
Corindus | $19M | 26 Feb 2019 | Massachusetts, United States | ||
Trice Medical | $18M | 14 Jan 2019 | Pennsylvania, United States | ||
Ablative Solutions | $77M | 03 Jan 2019 | San Jose, California, United States | ||
V-Wave | $70M | 27 Apr 2018 | Israel, North District, Israel | ||
Corindus | $25M | 16 Mar 2018 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.